13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001420506-25-003441
Total Value
$763.5M
Positions
18
Other Managers
0
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | LQDA | 8,118,892 | $184.6M | 24.18% |
| 2 | ABIVAX SA | AAVXF | 1,451,924 | $123.3M | 16.14% |
| 3 | MINERALYS THERAPEUTICS INC | MLYS | 2,772,654 | $105.1M | 13.77% |
| 4 | EXELIXIS INC | EXEL | 1,525,730 | $63.0M | 8.25% |
| 5 | REVOLUTION MEDICINES INC | RVMDW | 1,064,249 | $49.7M | 6.51% |
| 6 | AGIOS PHARMACEUTICALS INC | AGIO | 1,131,205 | $45.4M | 5.95% |
| 7 | AGIOS PHARMACEUTICALS INC | AGIO | 975,000 | $39.1M | 5.13% |
| 8 | ADMA BIOLOGICS INC | ADMA | 2,636,609 | $38.7M | 5.06% |
| 9 | EVOLUS INC | EOLS | 4,138,943 | $25.4M | 3.33% |
| 10 | MERUS N V | N5749R100 | 216,954 | $20.4M | 2.68% |
| 11 | XENON PHARMACEUTICALS INC | XENE | 444,565 | $17.8M | 2.34% |
| 12 | ANIKA THERAPEUTICS INC | ANIK | 1,435,130 | $13.5M | 1.77% |
| 13 | AVALO THERAPEUTICS INC | AVTX | 833,333 | $10.6M | 1.39% |
| 14 | TYRA BIOSCIENCES INC | TYRA | 696,825 | $9.7M | 1.28% |
| 15 | INHIBRX BIOSCIENCES INC | INBX | 236,383 | $8.0M | 1.04% |
| 16 | VERRICA PHARMACEUTICALS INC | VRCA | 923,910 | $4.0M | 0.52% |
| 17 | SELLAS LIFE SCIENCES GROUP I | SLS | 2,300,000 | $3.7M | 0.48% |
| 18 | AURA BIOSCIENCES INC | AURA | 227,174 | $1.4M | 0.18% |